Fitc-IETD-FMK is a combination of three different chemicals: fluorescein isothiocyanate (FITC), Iodoacetamide (IETD), and fluorescein maleimide (FMK). This combination is used to track different proteins in a cell, allowing researchers to identify a particular protein's location and behavior.
CAT No: HB00019
Fitc-IETD-FMK is a synthetic peptide-based inhibitor designed for specific and irreversible targeting of caspase-8, a key cysteine protease involved in the regulation of apoptosis and inflammatory signaling pathways. Structurally, it incorporates the IETD tetrapeptide recognition sequence linked to a fluoromethyl ketone (FMK) reactive group, enabling covalent modification of the enzyme's active site. The N-terminal fluorescein isothiocyanate (FITC) label confers strong fluorescent properties, allowing for direct visualization and tracking in cellular and biochemical assays. This compound is widely recognized in cell biology and molecular research for its dual functionality as both a potent biochemical inhibitor and a fluorescent probe, facilitating advanced studies of programmed cell death and protease activity.
Apoptosis research: Used extensively in apoptosis studies, the peptide-based inhibitor enables selective and irreversible inhibition of caspase-8 activity within living cells or cell lysates. By blocking caspase-8, researchers can dissect its specific role in extrinsic apoptotic signaling, distinguish between caspase-dependent and -independent pathways, and clarify the sequence of molecular events during programmed cell death. The ability to modulate caspase-8 function is essential for unraveling the complexities of death receptor-mediated apoptosis in diverse cell types.
Protease profiling: The FITC-conjugated structure supports direct visualization of enzyme-inhibitor interactions. When applied to cell extracts or intact cells, the compound binds active caspase-8, and its fluorescent label allows for detection by flow cytometry, fluorescence microscopy, or in-gel fluorescence analysis. This enables precise profiling of caspase-8 activation status, spatial distribution, and relative abundance under various experimental conditions, providing valuable insights into protease dynamics during cellular stress, immune signaling, or developmental processes.
Drug discovery screening: The compound's specificity and irreversible binding characteristics make it a valuable tool for high-throughput screening of novel modulators of apoptosis. By serving as a reference inhibitor in biochemical assays, it allows for the evaluation of candidate molecules that target caspase-8 or related proteases. Its use can help identify small molecules or biologics that modulate apoptotic pathways, supporting early-stage drug discovery and mechanistic pharmacology studies in oncology, immunology, and neurobiology research.
Cell signaling pathway analysis: Researchers leverage the inhibitor's selectivity to dissect complex cell signaling networks involving caspase-8. By selectively blocking caspase-8, it becomes possible to map downstream signaling events, study crosstalk between apoptosis and inflammation, and elucidate compensatory mechanisms that may be activated upon caspase inhibition. This application is particularly relevant in studies of immune cell activation, cytokine signaling, and the regulation of cell fate decisions in response to extracellular cues.
Live-cell imaging and tracking: The presence of the FITC moiety enables real-time imaging of caspase-8 activity and inhibitor localization within living cells. Scientists utilize this property to monitor the kinetics of caspase inhibition, visualize subcellular distribution, and assess the temporal dynamics of protease engagement during experimental treatments. Such imaging applications provide a powerful means to correlate biochemical inhibition with functional cellular outcomes, advancing the understanding of cell death mechanisms at both molecular and systems levels.
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More